BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5094519)

  • 1. Efficacy of oxytetracycline and a dithiosemicarbazone in the treatment of bovine anaplasmosis.
    Kuttler KL
    Am J Vet Res; 1971 Sep; 32(9):1349-52. PubMed ID: 5094519
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined treatment with a dithiosemicarbazone and oxytetracycline to eliminate Anaplasma marginale infections in splenectomized calves.
    Kuttler KL
    Res Vet Sci; 1972 Nov; 13(6):536-9. PubMed ID: 4648995
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunity to bovine anaplasmosis after elimination of the carrier status with oxytetracycline hydrochloride.
    Renshaw HW; Magonigle RA; Eckblad WP; Frank FW
    Proc Annu Meet U S Anim Health Assoc; 1976; (80):79-88. PubMed ID: 1078098
    [No Abstract]   [Full Text] [Related]  

  • 4. Application of various chemotherapeutic agents in experimental bovine anaplasmosis.
    Sharma SK; Banerjee DP; Gautam OP
    Ann Rech Vet; 1977; 8(3):307-13. PubMed ID: 606144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of five daily intravenous treatments with oxytetracycline hydrochloride on the carrier status of bovine anaplasmosis.
    Magonigle RA; Renshaw HW; Vaughn HW; Stauber EH; Frank FW
    J Am Vet Med Assoc; 1975 Dec; 167(12):1080-3. PubMed ID: 1194114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of naturally acquired chronic Anaplasma marginale infections with a long-acting oxytetracycline injectable.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1982 Dec; 43(12):2170-2. PubMed ID: 7165161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of the carrier state of bovine anaplasmosis with a long-acting oxytetracycline.
    Roby TO; Simpson JE; Amerault TE
    Am J Vet Res; 1978 Jul; 39(7):1115-6. PubMed ID: 677530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine anaplasmosis: elimination of the carrier state with injectable long-acting oxytetracycline.
    Swift BL; Thomas GM
    J Am Vet Med Assoc; 1983 Jul; 183(1):63-5. PubMed ID: 6874524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplasmosis: prevalence, treatment, and cattle to elk transmission studies.
    Renshaw HW; Magonigle RA; Stauber EH; Vaughn HW; Frank FW
    Proc Annu Meet U S Anim Health Assoc; 1975; (79):70-84. PubMed ID: 1078068
    [No Abstract]   [Full Text] [Related]  

  • 10. Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1984 Apr; 45(4):695-7. PubMed ID: 6731981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of oxytetracycline and a dithiosemicarbazone in eliminating Anaplasma marginale infection in splenectomized calves.
    Kuttler KL; Adams LG
    Res Vet Sci; 1970 Jul; 11(4):339-42. PubMed ID: 5499317
    [No Abstract]   [Full Text] [Related]  

  • 12. Elimination of the carrier state of bovine anaplasmosis with imidocarb.
    Roby TO; Mazzola V
    Am J Vet Res; 1972 Oct; 33(10):1931-3. PubMed ID: 5074698
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative persistence of capillary tube-agglutination and complement-fixation test reactions in cattle treated to destroy the carrier state of anaplasmosis.
    Jatkar PR; Kreier JR; Akin EL; Tharp V
    Am J Vet Res; 1966 Jan; 27(116):372-4. PubMed ID: 5950165
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of a second Anaplasma exposure on the success of treatment to eliminate Anaplasma carrier infections in cattle.
    Kuttler KL
    Am J Vet Res; 1983 May; 44(5):882-3. PubMed ID: 6869997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low levels of chlortetracycline for anaplasmosis.
    Richey EJ; Brock WE; Kliewer IO; Jones EW
    Am J Vet Res; 1977 Feb; 38(2):171-2. PubMed ID: 557303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a new oxytetracycline formulation against clinical anaplasmosis.
    Magonigle RA; Simpson JE; Frank FW
    Am J Vet Res; 1978 Sep; 39(9):1407-10. PubMed ID: 697150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine anaplasmosis: clinical, hematologic, and serologic manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period.
    Lincoln SD; Eckblad WP; Magonigle RA
    Am J Vet Res; 1982 Aug; 43(8):1360-2. PubMed ID: 7103219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary evaluation of a dithiosemicarbazone for the treatment of anaplasmosis.
    Kuttler KL; Zaraza H
    Res Vet Sci; 1970 Jul; 11(4):334-8. PubMed ID: 5499316
    [No Abstract]   [Full Text] [Related]  

  • 19. Babesia bigemina, Babesia argentina, and Anaplasma marginale: Coinfectious immunity in bovines.
    Todorovic RA; Gonzalez EF; Adams LG
    Exp Parasitol; 1975 Apr; 37(2):179-92. PubMed ID: 1123013
    [No Abstract]   [Full Text] [Related]  

  • 20. The inhibitory effect of a dithiosemicarbazone on acute infections of Anaplasma marginale.
    Roby TO; Amerault TE; Spindler LA
    Res Vet Sci; 1968 Nov; 9(6):494-9. PubMed ID: 5719106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.